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Abstract 
Idiopathic non-cirrhotic portal hypertension (INCPH) is a rare vascular liver disease that has 
attained a new interest in recent years. It is characterized by clinical signs of portal 
hypertension in the absence of cirrhosis or severe fibrosis and any known cause of portal 
hypertension.  Since much uncertainty exists about INCPH pathophysiology and no definite 
diagnostic tests are available, liver biopsy is an essential tool to achieve a definite diagnosis. 
Unfortunately, the histological diagnosis of INCPH is not always straightforward, since the 
characteristic lesions are unevenly distributed, vary greatly in their severity and are often very 
subtle, and not all are necessarily present in a single case. Furthermore, specifically for the 
characteristic portal vessel changes observed in INCPH, the terminology and definition is 
ambiguous, which adds complexity to the already complex clinical-pathological scenario. 
An international study group of liver pathologists and hepatologists pursued a consensus on 
nomenclature for the portal vascular lesions of INCPH.  Such standardization may assist 
pathologists in the recognition of such lesions and will possibly facilitate further 
advancement in this ﬁeld. 
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Introduction 
Idiopathic non-cirrhotic portal hypertension (INCPH) is a vascular liver disease of unknown 
etiology, characterized by clinical signs of portal hypertension (PH) in the absence of 
rhosis
1
. Therefore, INCPH is frequently revealed by splenomegaly, thrombocytopenia,
esophageal varices and/or variceal bleeding in patients with preserved liver function. The 
diagnosis of INCPH requires exclusion of any disorders known to cause portal hypertension 
in the absence of cirrhosis (e.g. infiltrative diseases, vascular malignancies, schistosomiasis, 
ngenital hepatic fibrosis, sarcoidosis), and other known causes of liver diseases
1,2
.
variety of terms was introduced for this non-cirrhotic liver disease
1-11
, such as Banti
syndrome, non-cirrhotic portal fibrosis, hepatoportal sclerosis, incomplete septal cirrhosis, 
obliterative portal venopathy and nodular regenerative hyperplasia. After recognizing that 
these names appear to reflect a disease entity, albeit with heterogeneous morphological 
ects
7
, the umbrella term INCPH was introduced to standardize the nomenclature
1
.
INCPH is relatively rare, particularly in western countries, but it is probably underdiagnosed 
misdiagnosed, since, on clinical presentation, it closely mimics “cryptogenic cirrhosis”8.
The lack of pathognomonic clinical and laboratory findings makes the histological 
examination of liver tissue samples critically important to achieve a definite diagnosis of 
CPH.
1,2  
 INCPH liver may show a variety of lesions
1-13
. The most characteristic encompass
a constellation of portal-periportal vascular changes, supposedly involved in the 
pathogenesis.  However, the histopathological diagnosis of INCPH is not always 
straightforward, since the characteristic lesions are unevenly distributed, vary greatly in their 
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severity, are often very subtle, and not all are necessarily present in an individual case
11,13
.
The limited sampling obtained by liver biopsy presents further challenge in recognizing 
relevant histological features.  Therefore, the pathologist who is not aware of the clinical
background, and/or does not include INCPH in the differential diagnosis, may miss the subtle 
morphologic changes of this condition. The scenario is even more complicated in that it is 
w recognized that in cases of INCPH, vascular lesions may be seen at earlier stages, when 
nical signs of PH are still lacking, or even never develop or are documented
12,14,15
.
Furthermore, the specificity and sensitivity
 
of these histopathological changes is currently 
unknown since they can be also seen outside the context of portal hypertension in chronic 
nditions of different etiologies
16,17
. To add to the complexity, standard nomenclature and
definition of characteristic INCPH portal lesions is lacking, which greatly contributes to 
problems in diagnosing this entity. 
The semantic confusion clearly reflects (but also contributes to) our uncertainties surrounding 
the pathogenesis and clinical meaning of the observed portal vascular lesions. Clear 
morphological definitions and terminology will enable follow-up studies, which can 
determine the utility of these definitions, and their potential impact on understanding 
pathophysiology, and/or in guiding clinical management of the patients.  
The present paper was written after a three-day meeting of the International Liver Pathology 
dy Group, also known as the “Elves”18, devoted to vascular liver lesions, which was held
in Padova (Italy) in 2015. We worked to arrive at a consensus on the definition and 
nomenclature for portal/periportal microvascular changes characteristic of INCPH, that can
assist clinical and investigative pathologists in recognizing the histopathologic features and 
applying them in a consistent fashion, necessary for gaining a better understanding of this 
disease. 
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For the sake of thematic focus, this manuscript is not a comprehensive review of the 
histopathology of INCPH. Therefore, pathological entities, such as nodular regenerative 
hyperplasia or incomplete septal cirrhosis, known to be associated with INCPH, or common 
accompanying lesions (sinusoidal dilatation, terminal hepatic vein enlargement) are not 
considered. For a comprehensive approach to the diagnosis of INCPH, the readers are 
erred to available literature
11,13,19
.  The goal of this paper is to recommend a system of
standardized nomenclature, so as to overcome the inconsistency of current terminology used 
for the characteristic INCPH portal/periportal vascular changes.  
Definitions and recommendations are based on what we have observed in routine liver 
biopsies, using routine stains (H&E and collagen stain).  We use adjunctive stains for specific 
purposes, for example reticulin stain is useful when nodular regenerative hyperplasia is 
suspected in INCPH. 
It is of worth emphasizing that the portal/periportal lesions not only may be variably 
combined in a single biopsy specimen, but different lesions may coexist in a same 
portal/periportal area and in some cases, it might be difficult to differentiate one from  the 
other.  Since small vascular structures are affected in INCPH, one should try to derive and 
construct their 3-dimensional behavior from the routine consecutive liver biopsy sections that 
are obtained for a liver biopsy. Besides providing a better sense of the 3-dimensional 
architecture of a lesion, following such lesions through all levels will help in identifying the 
different lesions properly. As was demonstrated by Crawford et al. in their study of normal 
er biopsies
20
, one-section-only may be not as informative as following findings-of-interest
through the many levels of a routine liver biopsy.  
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Normal histology of intrahepatic portal vasculature 
In normal adult liver biopsy, most portal tracts (PTs) contain portal vein, hepatic artery and 
bile duct profiles. Portal “dyads’ containing only hepatic artery and bile duct profiles, 
representing terminal PTs, are also commonly seen and should not be considered 
hological
20,21
. The successive branches of the smaller portal veins are the preterminal
portal venules, found in portal tracts of triangular cross sections, and the terminal portal 
venules (about 20–30 µm in diameter) surrounded by scanty connective tissue in portal tracts 
circular cross sections
21
.  In normal peripheral PTs, hepatic arteries and bile ducts exhibit
similar diameters, whereas portal vein profiles are on average three times greater in minimum 
meter and they can be up to 4 times greater
20
. Portal veins are entirely confined to the PT
and connect to sinusoids through the inlet venules. These are very short side branches, which 
have an endothelial lining with a basement membrane and scanty adventitial fibrous 
nnective tissue but no smooth muscle in their walls
20
. Inlet venules are usually not visible
in normal conditions. 
Portal and periportal changes in INCPH 
Portal vein narrowing 
In INCPH, the portal venous radicles show variable degrees of luminal narrowing, 
appearance or sclerosis 
1-13;19,22
.  This change usually occurs in a fibrotic PT. Indeed, round
rous PT enlargement is characteristic of INCPH
23
. The percentage of portal tracts involved
and the degree of fibrosis is variable. Since a normal PV branch is at least three times greater 
than the bile duct, comparing their caliber in the same PT may help one identify a narrowed 
PV (its caliber may be similar, or even smaller, to that of the bile duct). For larger portal 
veins, luminal narrowing may be recognized by identifying the smooth muscle fibers of the 
portal vein as revealing the original contour of this structure, and determining whether the 
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endothelial lining delineates a smaller luminal space. The endothelial lining may be 
highlighted by CD34 stain although obliteration of the portal vein lumen will also eliminate 
immunoreactive endothelial cells,   The presence of a circumferential profile of smooth 
scle fibers without any interior lumen is a sign of luminal disappearance.  Identification of 
narrowed portal vein in the smallest PTs may be very difficult. However, the presence of 
fibrosis along with an eccentrically-placed hepatic artery/bile duct pair is a helpful sign of 
portal vein disappearance.  This histologic sign is different than identifying a true hepatic 
artery/bile duct “dyad”, since the latter lacks fibrosis and has a delicate investment of 
extracellular matrix that wraps only around the hepatic artery and bile duct profiles, without 
any additional cross-sectional area. The overall impression of portal vein loss can also be 
supported by doing a “profile count” of one entire liver biopsy histologic section.  With a 
minimum of 7 portal tract profiles that are not at the edge of the biopsy sample, “paucity” of 
portal veins may be appreciated.  (The normal percutaneous liver biopsy has portal veins in 
70% of portal tracts, inclusive of both portal tracts with portal veins/hepatic arteries/bile ducts 
d “dyads”, with hepatic artery/bile duct pairs only)20.
In the literature, different terms have been used to refer to this alteration, which is regarded as 
 initial lesion of INCPH leading to increased intrahepatic resistance. Mikkelsen et al .
6
roduced the term “phlebosclerosis”. Obliterative portal venopathy2,12,24,25, portal vein
iteration
7
, hepato-portal sclerosis
9,26
, and small portal vein obliteration
27 
are other terms
commonly used. 
The term phlebosclerosis is misleading, since sclerosis of the PV wall is not invariably 
sent. Indeed, in the paper by Verheij et al.
28
 phlebosclerosis was defined as “a portal vein
with a reduced lumen in a fibrotic portal tract”.  As for the other terms, they have been 
differently defined and often used to refer either to the clinical syndrome or the entire 
ctrum of vascular changes seen in INCPH.  For example, Nayak and Ramalingaswami
24
,
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defined obliterative portal venopathy as “scarring and obliteration of small portal vein 
branches along with an increased number of small vascular channels within the portal tracts 
and incomplete thin fibrous septa”. As emphasized above, the entire spectrum of portal 
vascular changes is not necessarily found in every single case of INCPH, particularly in liver 
biopsy samples. Furthermore, the PV is not always obliterated, its lumen may be narrowed 
but still visible. Therefore, a term that refers only to the portal vein branch lesion, which may 
be an isolated change, and a more clear definition, is advisable. We suggest to name this 
lesion simply PV stenosis. The word stenosis comes from the ancient Greek and in medicine 
means pathological narrowing of a lumen, which may be more or less severe and even 
complete.  
Recommended term: PV stenosis  
Definition: Incomplete or complete obliteration of portal vein branches ± thickening of the 
wall (Fig. 1 and Table 1). 
Portal /periportal venous alterations 
Portal vascular spaces directly abutting upon the hepatic parenchyma at the limiting plate is a 
quent finding in INCPH
9,11,13,26,29,30
, giving the appearance of a prolapsed portal vein. This
is thought to be rarely or never seen in normal livers. Indeed, in normal liver, a portal vein is 
irely confined to the PT and separated from the hepatocytes by connective tissue.
21
tsumoto, who first observed this change in liver with Banti’s syndrome29 coined the term
errant vessel”. Ohbu et al.30 provided a detailed histopathological classification of portal
vascular changes in cases of non-cirrhotic PH, and called this alteration “type II aberrant 
vessel”  defining it as “an aberrant vessel connected to the peripheral portal vein”.  However, 
with the term “aberrant vessels” they covered both intra- and periportal vascular 
abnormalities, which do not necessarily coexist. Others applied the term aberrant vessels to 
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periportal vessels only
31,32.  Again, others called this lesion “herniated PV”26 or simply
considered it a component of “hepatoportal sclerosis” without using a specific terminology. 
other commonly used term is “shunt vessels”.9,19,33,34 However, some authors used “shunt
sels” to refer to periportal abnormal vasculature34. Furthermore, it is not clear whether
se abnormal vessels were really shunts. In the  study by Ohbu et al.
30
, using serial paraffin
sections, these vessels were seen opening into sinusoids, indicating they were not intrahepatic 
shunts connected to the terminal hepatic veins, but that they presumably  represented dilated 
inlet venules. Indeed, these vascular structures have a thin wall similar to the inlet venules.  
Waiting for a better understanding of the pathogenic events that lead to this change, we 
suggest keeping the most descriptive term among those available, that is “herniated PV”.  
This term immediately reflects the impression we have looking at the biopsy. We strongly 
recommend abandoning all the other terminologies. 
Recommended term: herniated PV 
Definition: A portal vein from the portal tract directly abutting periportal parenchyma (Fig. 2 
and Table 1). 
Increase in the number of portal vascular spaces 
An increased number of thin walled vascular spaces in PTs, often without an effective portal 
vein, is a well-recognized morphologic feature of INCPH, first described by Mikkelsen  et al. 
1965
6
.
 
  This finding has also been included in the description of hepatoportal sclerosis
10
.
yak et al.
7
 considered them as obliterative change of smaller branches and defined them as
“few small capillary-like venous channels dispersed in the fibrosed portal tracts”. However, 
 size of these vessels was variable.  Krasinksas et al.
16
 referred to such alteration as
“fragmentation” of portal vein radicles and included it under the umbrella of aberrant vessels. 
her terms used in the literature included “PT angiomatosis”, “angiomatoid lesion”23 and
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“angiomatous transformation of the PT”35. It is very unlikely that such an anomaly reflects
neoplastic or malformed vascular proliferation, as the terminology might suggest; its 
pathogenesis remains unknown. We suggest discontinuing the use of these different names 
and replace them with the descriptive, non-committal term, “hyper-vascularized portal tract”, 
which simply means that there are more vascular structure than expected in a normal PT. 
Recommended term: hyper-vascularized portal tract. 
Definition: multiple thin walled vascular spaces in PT (Fig. 3 and Table 1). 
Periportal vessels 
Periportal changes in INCPH consist of abnormal vascular spaces immediately adjacent to a 
tal tract, which may or may not contain a normal PV
11,13,19,26,30
. Periportal abnormal
vascular spaces may be single or multiple with lumen of different sizes. Similar changes have 
been also found in cases of extrahepatic portal vein obstruction and nodular regenerative 
hyperplasia, both entities known to be associated with non-cirrhotic portal hypertension. The 
gin of these vascular spaces is also not clear. Fukuda et al.
36
 provided evidence that they
were portal in nature, on autopsy and biopsy materials of idiopathic PH, and in experimental 
animal models. The various terms used to refer to this abnormality include  aberrant 
sels
16,29,30
, cavernous transformation
26
, paraportal shunting vessels
7 
and
gasinusoids
37,38. As already observed, “aberrant vessels” has been used as an umbrella
term also including intra portal vessel changes.  Both angiomatoid malformation and 
cavernous transformation are ambiguous terms. In the common medical language, 
malformation means deviation from normal morphology usually on a genetic/congenital base. 
Cavernous transformation of the portal vein currently indicates a rare condition consisting of 
portosystemic or porto-portal collaterals that develop as long-term sequelae of portal vein 
thrombosis. We also discourage the use of the terms “paraportal shunting vessels” and 
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“megasinusoids” since neither the shunt function nor the sinusoidal origin are proven. In 
addition, the term megasinusoid has been used to describe sinusoidal ectasia, which is a 
common accompanying change in cases of INCPH. 
To avoid confusion about the unclear origin of this vascular abnormality, we again 
recommend using a purely descriptive term and suggest to name this finding “periportal 
normal vessels” 
Recommended term: periportal abnormal vessels. 
Definition: single or multiple thin-walled vascular spaces of different caliber outside, but in 
close contact with the portal tract (Fig. 4 and Table 1). 
Conclusion 
Aiming at simplification and providing a basis for standardization, the nomenclature 
proposed herein is intended to be descriptive enough so that it can be used without 
pathophysiological implications. Our knowledge of the causes and morphogenesis of vascular 
al erations and of natural history in INCPH is still unsatisfactory. The use of consistent 
nomenclature and definitions in both clinical and research setting will facilitate future 
investigations and standardization of diagnostic criteria. 
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Table 1: summary of proposed nomenclature and definition of portal/periportal INCPH 
lesions. 
posed term Definition Terms to be discarded 
Portal vein stenosis Incomplete (Fig. 1A) or 
complete (Fig. 1B) 
obliteration of portal vein 
branches ± thickening of the 
wall 
Phlebosclerosis; obliterative 
portal venopathy; portal vein 
obliteration; hepato-portal 
sclerosis 
Herniated portal vein A portal vein from the portal 
tract directly abutting 
periportal parenchyma (Fig. 
2A-B) 
Aberrant vessels; 
hepatoportal sclerosis; shunt 
vessels 
Hyper-vascularized portal 
tract 
Multiple thin walled vascular 
spaces in PT (Fig 3A-B) 
Fragmentation of portal vein 
radicles; portal tract 
angiomatosis; angiomatoid 
lesion; angiomatous 
transformation of portal tract 
Periportal abnormal vessels Single or multiple thin-walled 
vascular spaces of different 
caliber outside, but in close 
contact with the portal tract 
(Fig. 4A-B) 
Aberrant vessels; cavernous 
transformation; paraportal 
shunting vessels;  
megasinusoids 
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Figure legends 
Fig. 1:   Sclerotic portal tracts with partial (A) and complete (B) stenosis of the portal vein 
branch. (H&E; 20X and 60x). 
. 2A and 2B): Examples of herniated portal veins (H&E; 20x and 40x) 
. 3A and 3B: Hyper-vascularized portal tract is characterized by the presence of multiple 
vascular profile with thin wall and lumen of different caliber. In panel B an abnormal 
periportal vessel (arrowhead) is also visible (H&E; 20x). 
Fig. 4: Abnormal periportal vessels (*) have thin walls and small (A,B) or large (B) caliber. 
In both cases, a normal portal vein branch is no visible (H&E; 20x and 40x). 
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